TMDX TransMedics Group, Inc.
$80.28 -3.27%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-3.27%
YTD
-30.30%
P/E
18.03
P/B
8.79
ROE
33%
Div yield
—
Beta
1.13
Market cap
$2.7B
RSI (14)
42
Next earnings
Oct 27, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$83.87
Close
$80.28
VWAP (n/a)
—
Day high
$84.05
Day low
$80.13
Volume
571K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
TransMedics Group (TMDX) Stock Looks Below Fair Value On Earnings
Yahoo Finance · Oct 2
TransMedics Group (TMDX) Could Be 19% Undervalued If Its Growth Narrative Holds
Yahoo Finance · Oct 2
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?
Yahoo Finance · Sep 29
Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?
Yahoo Finance · Sep 3
TransMedics to Present at Upcoming September Investor Conferences
Yahoo Finance · Aug 31
TransMedics Targets $2B Opportunity With Kidney Push, European Expansion
Yahoo Finance · Aug 18
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 10, 2026 View → 10-Q Aug 4, 2026 View → 8-K Aug 4, 2026 View → 8-K May 21, 2026 View → 10-Q May 5, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell TMDX. Try it in the Lab to size a position and see the risk.